We are live on
!
Find out more
EIM
Essex Investment Management Portfolio holdings
AUM
$632M
1-Year Est. Return
95.36%
This Fund
S&P 500
This Quarter
Est. Return
-14.85%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$637M
AUM Growth
-$214M
(-25%)
Cap. Flow
-$70.8M
Cap. Flow
% of AUM
-11.11%
Top 10 Holdings %
Top 10 Hldgs %
18.21%
Holding
581
New
183
Increased
73
Reduced
207
Closed
105
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$14.4M |
| 2 |
Netflix
NFLX
|
+$9.91M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$8M |
| 4 |
Teladoc Health
TDOC
|
+$7.16M |
| 5 |
Ciena
CIEN
|
+$6.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$10.1M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$10M |
| 3 |
Biogen
BIIB
|
+$8.82M |
| 4 |
Alibaba
BABA
|
+$8.42M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$5.33M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 20.95% |
| 3 | Industrials | 11.87% |
| 4 | Financials | 8.28% |
| 5 | Consumer Discretionary | 8.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Build-A-Bear
BBW
$466M
| – | – |
-36,751
| Closed | -$333K |
|
477
Baker Hughes
BKR
$62.8B
| – | – |
-8,124
| Closed | -$275K |
|
478
Bristol-Myers Squibb
BMY
$132B
| – | – |
-9,981
| Closed | -$620K |
|
|
BPMC
479
DELISTED
Blueprint Medicines
BPMC
| – | – |
-19,137
| Closed | -$1.49M |
|
|
CRON
480
Cronos Group
CRON
$1.19B
| – | – |
-149,389
| Closed | -$1.66M |
|
|
CTLP
481
DELISTED
Cantaloupe
CTLP
| – | – |
-222,345
| Closed | -$1.6M |
|
482
Cavco Industries
CVCO
$4.64B
| – | – |
-17,664
| Closed | -$4.47M |
|
483
CVS Health
CVS
$122B
| – | – |
-20,338
| Closed | -$1.6M |
|
484
Devon Energy
DVN
$48.7B
| – | – |
-35,641
| Closed | -$1.42M |
|
485
eBay
EBAY
$46B
| – | – |
-54,650
| Closed | -$1.8M |
|
486
Diamondback Energy
FANG
$55.6B
| – | – |
-23,409
| Closed | -$3.17M |
|
487
Freeport-McMoran
FCX
$94.7B
| – | – |
-177,945
| Closed | -$2.48M |
|
|
FOLD
488
DELISTED
Amicus Therapeutics
FOLD
| – | – |
-118,789
| Closed | -$1.44M |
|
489
Gilead Sciences
GILD
$170B
| – | – |
-30,553
| Closed | -$2.36M |
|
490
Golar LNG
GLNG
$5.5B
| – | – |
-85,589
| Closed | -$2.38M |
|
491
First Internet Bancorp
INBK
$258M
| – | – |
-16,585
| Closed | -$505K |
|
492
Insmed
INSM
$28.5B
| – | – |
-22,370
| Closed | -$452K |
|
493
Inuvo
INUV
$14.8M
| – | – |
-20,112
| Closed | -$125K |
|
494
Leidos
LDOS
$17.8B
| – | – |
-25,483
| Closed | -$1.76M |
|
495
Limbach Holdings
LMB
$537M
| – | – |
-17,851
| Closed | -$201K |
|
496
Limoneira
LMNR
$252M
| – | – |
-10,162
| Closed | -$265K |
|
|
MAG
497
DELISTED
MAG Silver
MAG
| – | – |
-17,457
| Closed | -$142K |
|
498
Magnite
MGNI
$3.53B
| – | – |
-93,155
| Closed | -$335K |
|
|
MOMO
499
Hello Group
MOMO
$869M
| – | – |
-60,884
| Closed | -$2.67M |
|
500
McEwen Inc
MUX
$1.14B
| – | – |
-31,395
| Closed | -$609K |
|
Similar funds
BI
KCMH
SFM
VIM
AP
TTSTC
WCM
FTC
Essex Investment Management's Q4 2018 Portfolio in Review
As of Q4 2018, Essex Investment Management held 581 positions worth $637M, down 25% from $851M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Essex Investment Management withdrew a net $70.8M in Q4 2018, closing 105 positions and reducing 207 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $5.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Essex Investment Management opened a new position in NVIDIA worth $10.1M.
- Essex Investment Management's largest Q4 2018 buy was NVIDIA: 3,018,520 shares worth $10.1M.
- Essex Investment Management added most to VanEck Junior Gold Miners ETF in Q4 2018, an estimated $8M increase.
- Essex Investment Management's biggest Q4 2018 reduction was Apple, cutting an estimated $10.1M.
- Essex Investment Management fully exited Regeneron Pharmaceuticals in Q4 2018, selling an estimated $5.1M.
- Essex Investment Management's ten largest holdings make up 18% of its $637M portfolio in Q4 2018.
- Essex Investment Management opened 183 new positions and closed 105 in Q4 2018.
- Essex Investment Management's portfolio value fell 25% quarter-over-quarter to $637M.
Based on Essex Investment Management's 13F filing for Q4 2018, filed 6 Feb 2019.